Literature DB >> 8358989

Sneddon's syndrome and phospholipid antibodies.

H A Mesa1, B Lang, M Schumacher, P Vaith, H H Peter.   

Abstract

We present a case of Sneddon's syndrome with high titers of antiphospholipid antibodies (APLA), in which the leading symptom was an incapacitating memory defect. MRI revealed vasculitic lesions of the central nervous system (CNS). Therefore immunosuppressive therapy was started with steroids and cyclophosphamide pulses. The transient beneficial effects of such a therapy will be discussed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8358989     DOI： 10.1007/bf02231537

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  32 in total

1.  Sneddon's syndrome and primary anti-phospholipid syndrome (PAPS)

Authors:  R A Asherson; M A Khamashta
Journal:  Br J Dermatol       Date:  1990-01       Impact factor: 9.302

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

3.  Sneddon's syndrome. Case report and literature review.

Authors:  R P Bruyn; J P van der Veen; A J Donker; J Valk; E C Wolters
Journal:  J Neurol Sci       Date:  1987-07       Impact factor: 3.181

4.  Sneddon's syndrome and anticardiolipin antibodies.

Authors:  J Montalbán; J Ordi; J Barquinero; M Vilardell
Journal:  Stroke       Date:  1988-06       Impact factor: 7.914

5.  Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.

Authors:  M A Khamashta; E N Harris; A E Gharavi; G Derue; A Gil; J J Vázquez; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

6.  Antiphospholipid antibodies and Sneddon's syndrome.

Authors:  J A Vargas; M Yebra; M L Pascual; L Manzano; A Duŕantez
Journal:  Am J Med       Date:  1989-11       Impact factor: 4.965

7.  Anticardiolipin antibodies in autoimmune thrombocytopenic purpura.

Authors:  E N Harris; A E Gharavi; U Hegde; G Derue; S H Morgan; H Englert; J K Chan; R A Asherson; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

8.  Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.

Authors:  R A Asherson; J K Chan; E N Harris; A E Gharavi; G R Hughes
Journal:  Ann Rheum Dis       Date:  1985-12       Impact factor: 19.103

9.  Recurrent ischemic attacks in two young adults with lupus anticoagulant.

Authors:  G Landi; M V Calloni; M Grazia Sabbadini; P Mannuccio Mannucci; L Candelise
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

10.  Sneddon's syndrome: an antiphospholipid antibody syndrome?

Authors:  S R Levine; S L Langer; J W Albers; K M Welch
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.